Journal of Diabetes Investigation · 2014 · 18 citations · 16 references
MedicineEndocrinologyPharmacotherapyAndrologyEndocrine PharmacotherapyMen's HealthDiabetes ControlDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlOral Antidiabetic AgentsBlood Glucose RegulationLipid Profile ChangesOral Antidiabetic MedicationsOral Antidiabetic TherapyPhase Iv Clinical TrialsPhase Iv TrialsSex Hormone-binding GlobulinTestosterone Therapy
AIMS/INTRODUCTION: To evaluate the effect of sulfonylurea (glimepiride)-based oral antidiabetic agents on testosterone levels in middle-aged men with type 2 diabetes. MATERIALS AND METHODS: As a substudy, 15 participants from the phase IV clinical trial of glimepiride (GREAT study) of middle-aged men with type 2 diabetes were included in the current study. After enrolment, the initial dose of oral glimepiride was 1 mg/day. The dose was titrated according to blood glucose levels and the participants were treated for 16 weeks. Meanwhile, another 15 healthy age- and body mass index-matched male subjects were randomly selected as the healthy control group. RESULTS: Compared with the healthy control group, the middle-aged men with type 2 diabetes had significantly decreased total testosterone levels and a lower testosterone secretion index. Blood glucose and lipid profile levels were significantly improved after 16 weeks of treatment with no significant differences in bodyweight and waist circumference compared with baseline values. Recorded changes in luteinizing hormone, follicle-stimulating hormone and sex hormone-binding globulin levels were not statistically significant. However, total testosterone levels were significantly increased and testosterone secretion index values were significant higher than those of the baseline. CONCLUSIONS: It is highly possible that sulfonylurea as an initial treatment can recover the decreased total serum testosterone levels and testosterone secretion index values in middle-aged men with type 2 diabetes.
16
Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men
Eric L. Ding, Yiqing Song, JoAnn E. Manson et al. · New England Journal of Medicine · 2009 · 723 citations · Full text
Varant Kupelian, Stephanie T. Page, Andre B. Araujo et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 563 citations
Sex hormones, inflammation and the metabolic syndrome: a population-based study
DE Laaksonen, Leo Niskanen, Kari Punnonen et al. · European Journal of Endocrinology · 2003 · 442 citations
Medicine, Endocrinology, Andrology +16
Testosterone Concentrations in Diabetic and Nondiabetic Obese Men
Sandeep Dhindsa, Michael G. Miller, Cecilia McWhirter et al. · Diabetes Care · 2010 · 346 citations · Full text
Medicine, Endocrinology, Andrology +16